Sohan Roy, well-known Indian businessman settled in UAE, created a remarkable moment when he became the pioneering Indian to ...
Stifel has recently initiated Cullinan Therapeutics Inc (CGEM) stock to Buy rating, as announced on May 1, 2024, according to Finviz. Earlier, on April 15, 2024, William Blair had initiated the stock ...
Nicholas Cullinan, the new director of the British Museum, has announced a groundbreaking $1.3 billion transformation plan, ...
Phase 1 clinical trial is designed to assess the safety, pharmacokinetics and initial clinical activity of CLN-978 for patients with systemic ...
WMBD Peoria on MSN1d
City Hall to buy two buildings and a parking deck in Downtown PeoriaIn an effort to control the development of a Downtown Peoria block, CIty Hall wants to buy two buildings and a parking deck ...
BTIG analyst Julian Harrison maintained a Buy rating on Cullinan Management (CGEM – Research Report) yesterday and set a price target of ...
Sept. 17, 2024 (GLOBE NEWSWIRE) -- Cullinan Therapeutics, Inc. (Nasdaq: CGEM), a biopharmaceutical company focused on developing modality-agnostic targeted therapies, today received Human Research ...
The Human Research Ethics Committee (HREC) in Australia has granted clearance for Cullinan Therapeutics to commence an ...
The newly-evolved Rolls-Royce Cullinan Series II appeals to the discerning tastes of ultra-luxury SUV enthusiasts through ...
Sept. 14, 2024 (GLOBE NEWSWIRE) -- Cullinan Therapeutics, Inc. (Nasdaq: CGEM), a biopharmaceutical company focused on developing modality-agnostic targeted therapies, today shared updated data in ...
Shares of Cullinan Therapeutics, Inc. (NASDAQ:CGEM – Get Free Report) have been assigned a consensus rating of “Buy” from the six ratings firms that are currently covering the stock ...
Rolls-Royce has unveiled the Cullinan Series II, marking a bold evolution of its renowned super-luxury SUV. This latest ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback